Cardiopulmonary function and aerobic exercise in Parkinson's: a systematic review of the literature by Aburub, A et al.
This article has been accepted for publication and undergone full peer review but has 
not been through the copyediting, typesetting, pagination and proofreading process 
which may lead to differences between this version and the Version of Record. Please 






Cardiopulmonary function and aerobic exercise in Parkinson’s: 
a systematic review of the literature  
Aseel Aburub MSc 
Lecturer, School of Allied Health Professions, Faculty of Medicine and Health 
Sciences, Keele University, United Kingdom 
 Sean J Ledger MSc 
Senior Lecturer, School of Health, Medical and Applied Sciences, Central Queensland 
University, Australia 
 Julius Sim PhD 
Professor, School of Allied Health Professions and School of Primary, Community and 
Social Care, Faculty of Medicine and Health Sciences, Keele University, United 
Kingdom 
 Susan M Hunter PhD 
Senior Lecturer, School of Allied Health Professions, Faculty of Medicine and Health 
Sciences, Keele University, United Kingdom 
 
*Address all correspondence to Aseel Aburub, School of Allied Health Professions, 
Keele University, Keele, Staffordshire, ST5 5BG, United Kingdom.  
Email: a.a.m.aburub@keele.ac.uk   Phone number: +44 (0) 1782 733809 
Word count: 2577 
This article is protected by copyright. All rights reserved.
  
Keywords: Pulmonary function; spirometry; cardiopulmonary exercise test; walking 
economy; aerobic exercise; Parkinson’s. 
 
Abstract  
Background: Cardiorespiratory impairments are considered the main cause of mortality in 
the late stages of Parkinson’s. Aerobic exercise has been shown to improve pulmonary 
function in asthmatic patients and in healthy people. However, effects of aerobic exercise on 
cardiopulmonary function in people with Parkinson’s have not been investigated. Therefore, 
this study aimed to review the effects of aerobic exercise on cardiopulmonary function in 
people with Parkinson’s. 
Method: A systematic search was conducted using MEDLINE, AMED, and CINHAL Plus, and 
relevant associated keywords, from January 1970 to January 2020. Inclusion criteria for the 
studies were: aerobic exercise as part of the intervention, pulmonary function test and/or 
cardiopulmonary exercise test as outcome measures.  
Results: In total, 329 citations were identified from the search, of which nine were included 
in this review. In general, aerobic exercise was found to have positive effects on cardiac 
function for people with Parkinson’s, but there is a lack of studies on the effects of aerobic 
exercise on pulmonary function.  
Conclusion: People with early stages of Parkinson’s may experience positive effects of 
aerobic exercise on cardiac fitness. Further research is needed in this area, particularly into 
the effects of aerobic exercise on pulmonary function in early stages of the disease.  
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Parkinson's is the most common age-related, neurodegenerative motor disorder, with 
unknown cause [1]. Respiratory problems, which can present as either a restrictive or an 
obstructive pattern, are the main cause of morbidity and mortality in the end stages of 
Parkinson’s [2]. Restrictive pulmonary disease, or restrictive pattern, is characterized by 
decreased lung volumes, increased work of breathing, and inadequate ventilation and 
oxygenation, and includes pulmonary fibrosis, pneumonia and pulmonary edema [2]. 
Obstructive pulmonary disease is generally characterized by inflamed and collapsible airways 
and impediment to airflow during exhalation, which is commonly exhibited in asthma, 
chronic bronchitis, and emphysema [2]. Most people with Parkinson’s (PwP) do not report 
respiratory problems in the early stages of the disease, although evidence from cross-
sectional studies has highlighted abnormalities in pulmonary function [3-6]. These might be 
due to the low levels of physical activity caused by motor symptoms, during which 
respiratory function is unchallenged and, consequently, respiratory impairment or 
complaints are not manifest [6].  
 
Aerobic exercise refers to the use of oxygen to adequately meet energy demands during 
physical exercise [7]. In the general population, heart rate (HR) and respiratory rate increase 
during aerobic exercise in order to fulfil demands of the exercising skeletal muscles [7]. 
According to the new UK Chief Medical Officer’s Physical Activity Guidelines [8], older adults 
should aim to accumulate at least 150 minutes per week of moderate-intensity aerobic 
activity to gain health benefits, including maintenance of good physical and mental health, 
wellbeing, and social functioning. Additionally, it has been found that regular aerobic 
exercise, such as walking, cycling or swimming, of 30 to 60 minutes three times per week can 
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decrease blood pressure, improve oxygen consumption, and decrease shortness of breath in 
the general population [9]. However, these effects have not been widely explored in PwP. 
 
A number of studies [for example: 10, 11] have investigated the effects of exercise and 
physical activity on balance, mobility, quality of life and cognitive function in PwP. However, 
there has been limited research on cardiopulmonary responses to exercise in PwP. 
Therefore, this review evaluated the published literature to answer the following research 
question: what are the effects of aerobic training on cardiopulmonary function in PwP? 
 
Methods 
Purpose: the study objective was to review the reported effects of aerobic exercise on 
cardiopulmonary function and walking economy, and the effects of interventions that might 
improve cardiopulmonary function in PwP. To achieve this, the primary outcomes are 
defined as pulmonary function test (PFT) variables including: forced expiratory volume in 
one second (FEV1); forced vital capacity (FVC); and FEV1/FVC, and cardiopulmonary exercise 
test (CPET) variables including: oxygen uptake at maximal exertion (V�O2max); and oxygen 
uptake at peak exertion (V�O2peak). Secondary outcome measures include maximum HR 
(HRmax) and peak HR (HRpeak), CPET duration, blood pressure pre- and post-CPET and walking 
economy. The study aimed to conduct a meta-analysis for the primary outcome measures, 
where feasible. If conducting meta-analysis was not possible, the study aimed to conduct a 
narrative synthesis.   
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Design: a systematic review with quality assessment and narrative synthesis of relevant 
published literature.  
 
Search strategy: a search was conducted through EBSCO using the following electronic 
databases: MEDLINE, AMED, and CINHAL Plus. The search was limited to full-text English-
language articles and excluded conference abstracts. The selected databases were chosen 
because of the likely availability of Parkinson’s physiotherapy- and exercise-related articles 
in these databases. The databases were searched for studies published between 1st January 
1970 to 1st January 2020, with results of the searches managed using Endnote Version X7 
(Clarivate Analytics, Philadelphia, USA). Table 1 summarizes the combinations of keywords 
included in the search strategies.  
 
Randomized controlled trials, controlled clinical trials, and controlled quasi-experimental 
studies investigating the effects of aerobic exercise on cardiopulmonary function in PwP 
were included. Studies that did not include either a CPET or a PFT were excluded. Pre-clinical 
studies (animal model studies) were excluded. Single-group, uncontrolled, and single-case 
studies were excluded.  
 
Study selection  
Following the search and subsequent removal of duplicates, titles and abstracts were 
screened by two researchers (AA, SMH) for relevance. Full texts of relevant studies were 
then screened for eligibility against inclusion and exclusion criteria.  
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Data extraction 
The following data were extracted from the included studies and presented in a table: age, 
sex, disease severity and sample size. Exercise intervention mode, intensity, duration and 
frequency were noted.  
 
Quality assessment of the included studies  
Quality assessment of included trials was performed using the PEDro Scale, a valid and 
reliable tool for assessment of quality of interventional studies specifically related to 
physical therapy interventions [12, 13]. The PEDro scale contains 11 items (see table 2), and 
studies are awarded between 0 and 10 points, depending on the number of criteria they 
meet (the first item is not used to calculate the summary score). Studies with scores of four 
points or more were classified as “high-quality”, whereas studies with three points or fewer 
were classified as “low-quality” [12]. PEDro scores for the studies were not used as an 
inclusion or exclusion criterion, but as a basis for best-evidence synthesis and to determine 
the strengths and weaknesses of each study.  
 
Results  
The systematic search identified 329 citations, of which 132 were duplicates. Consequently, 
197 citations were screened from titles and abstracts and 172 were considered not to be 
relevant. Of the 25 remaining studies, 16 were excluded as they did not include aerobic 
exercise or CPET or PFT, or they were animal model studies or single-case studies. 
Consequently, nine studies were included in the review: one was a non-randomized 
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controlled pilot study [14] and eight were randomized controlled trials [15–22]. Figure 1 
represents the findings of the search.  
   
Quality assessment 
Due to the nature of exercise interventions, no studies included blinding of subjects or 
investigators to the intervention allocation; therefore, no points were awarded on the PEDro 
Scale for items 5 and 6. Table 2 shows the PEDro quality assessment scores for the included 
studies. Scores ranged from 5 [14] to 8 [16–21]. 
 
To assess the feasibility of running meta-analysis, data were extracted and summarized in 
table 3, and focused on: pulmonary function test variables; the protocols used for CPET; 
mode of the test: treadmill or cycle test; CPET test primary outcomes (V�O2max and V�O2peak); 
secondary outcomes including HRmax; HRpeak; CPET test duration; blood pressure (BP) pre- 
and post-CPET; and walking economy. None of the studies investigated the effects of aerobic 
exercise on pulmonary function; therefore, no data related to FEV1, FVC and FEV1/FVC could 
be reported. Meta-analysis of data was not undertaken owing to the heterogeneity of the 
studies, specifically: inclusion/exclusion criteria, exercise test protocol, mode of exercise test 
(cycle or treadmill), exercise intensity (maximum or sub-maximum), and physiological 
outcomes (HR, V�O2peak, V�O2max), and systolic or diastolic BP). Instead, a narrative review was 
conducted. Furthermore, it was not possible to calculate effect sizes from the data provided 
in the published papers. Authors were contacted by email to request the additional relevant 
data, but none responded.  
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Effects of aerobic training on cardiopulmonary function 
Seven studies assessed the effects of aerobic training on cardiopulmonary function. Aerobic 
training (including walking overground, treadmill walking and stationary cycling) in PwP was 
reported to improve V�O2peak  [14, 15], decrease breathlessness [16], increase maximum 
workload tolerated [14], reduce BP [17], and increase test duration of the CPET [17, 18]. 
However, two studies reported a decrease, rather than an increase, in V�O2peak after aerobic 
training [16, 19], and one study reported no significant differences between the exercise 
group and the usual activity group [20].  
 
Frequency and duration of the exercise  
Frequency of the aerobic training ranged from two to five times per week, with exercise 
program durations ranging from six to 24 weeks. For example, Bergen et al.  [14] 
investigated the effects of a 3-times/week exercise program for 16 weeks (n=4); Bridgewater 
and Sharpe [18], Ridgel et al. [20] and Shulman et al. [19] investigated the effects of a 3-
times/week exercise program for 12 weeks (n=13, n=24 and n=67, respectively); whilst 
Mavrommati et al. [17] investigated the effects of a program 2 times/week for 24 weeks 
(n=83). Shorter program durations of 3 times/week for 7 weeks (n=26) [16] and 4 days/week 
for 4 weeks  (n=20) [15] have also been investigated. Although the duration of the aerobic 
exercise intervention varied in these studies, all of them reported improvement in exercise 
test outcomes, including HR and V�O2, except two studies [16, 19]. 
 
It is not clear if there is a dose-effect relationship. However, Bergen et al.  [14] reported that 
V�O2peak significantly improved by 26%, from 19.5 ml.kg.min-1 to 24.5 ml.kg.min-1, after 16 
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weeks of exercise. Mavrommati et al. [17] reported a mean (SD) improvement in V�O2 of 
1.66(0.09) ml.kg.min-1, although the intervention included a 24-week exercise program. 
Bridgewater et al. [18] only reported changes in HR, not in V�O2. Two studies [14, 23] did not 
report the mean or SD or the mean difference for V�O2. Additionally, these studies used 
different exercise tests (i.e. cycle CPET or treadmill CPET) and different exercise test 
protocols. Thus, these results need to be treated with caution due to this heterogeneity.  
 
Intensity of the exercise  
Only one study [19] investigated the effects of different exercise intensities on V�O2, and the 
other six studies investigated only the effects of specific intensities. To study the effects of 
different intensities of aerobic exercises, Shulman et al. [19] assessed V�O2 and gait speed 
after high- and low-intensity treadmill walking training. A high-intensity treadmill group 
(n=34, Hoehn and Yahr (H&Y) stages I–III) started at 40%–50% of maximal HR and increased 
up to 70%–80%. In contrast, the low-intensity treadmill walking training (n=33, H&Y stages I-
III) started at 20% and increased up to 40%–50% of maximal HR. Both high- and low-intensity 
treadmill training improved V�O2, to a similar degree, with a 1.54 ml.kg.min-1 increase after 
low-intensity and 1.53 1.54 ml.kg.min-1 increase after high-intensity treadmill training. 
However, Ridgel et al. [20] reported no change in V�O2 or any other markers of cardiovascular 
response after moderate intensity aerobic training involving 44 PwP, at H&Y stages I-III. It 
should be noted that this study included a combined aerobic-strengthening program and 
was not solely focused on aerobic training. Other studies reported using intensities of: 60–
70% [14], 65–85% [18], 59–60% [16], 55–85% [17] maximal HR. Corbianco et al. [15] used 
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the Borg scale for assessing rate of perceived exertion (RPE) as an intensity to do exercise 
with score of 13 to 15 on the 20-point Borg scale [15].  
 
The effects of aerobic exercise on walking economy 
Walking economy is defined as the energy required to perform at a submaximal walking 
intensity [24]. It is measured by the rate of V�O2 per distance during walking [24]. Only two 
studies [21, 22] investigated the effect of aerobic training on cardiopulmonary function and 
walking economy in PwP. Table 3 summarizes the main findings of these two studies. 
 
Schenkman et al. [21] examined the effect of 30 minutes of aerobic exercise, three 
times/week for 16 weeks, and reported decrease in oxygen consumption (mean difference = 
–1.2 ml.kg.min-1, 95% CI = –1.9 to –0.5). However, Schenkman’s study assessed the energy 
required to walk on the treadmill, not on an overground surface that is more akin to 
functional mobility. Only one study [22] examined the effect of treadmill training and 
overground walking on overground walking economy in PwP. To achieve this, 22 PwP (H&Y 
stage I–II) were randomly allocated to an overground walking intervention group and a 
treadmill training group for five weeks. Both groups were required to walk at their preferred 
speed three times/week for five weeks. Results of the study indicated that treadmill training, 
but not overground training, reduced overground energy expenditure by a mean (SD) of 
15.54 (3.24) ml.kg.min-1 versus 19.40 (4.78) ml.kg.min-1, respectively. This may have been 
because the controlled speed of the treadmill elicited a higher intensity of exercise for the 
duration of the activity than overground walking. Although this study used a small sample 
(n=22), it is the only study to have assessed overground walking economy in PwP.  




This review has shown that only a small number of studies have investigated the effects of 
aerobic exercise on cardiopulmonary function in Parkinson’s. It has indicated that aerobic 
exercise could help in improving cardiac fitness. Aerobic exercise is considered to be a 
cheap, widely accepted self-managed intervention. Most of the studies included in the 
review used similar intensities and frequencies recommended by the World Health 
Organization (WHO) (30–45 minutes of moderate intensity, three times per week) [26]. 
However, none of these studies investigated the effects of aerobic exercise on pulmonary 
function. Thus, future research is recommended to investigate the effects of aerobic 
exercise on cardiac fitness and pulmonary function in PwP, with an appropriately calculated 
sample size and different disease severities. 
 
The decrease in walking economy in PwP leads to excess fatigue and, in turn, could affect 
independence and quality of life [24]. However, only two studies [21, 22] studied walking 
economy. Investigating walking economy could help an understanding of whether PwP need 
to consume more energy to walk, and of how different interventions could affect energy 
consumption. There is a lack of knowledge of the factors that might affect walking economy. 
Further studies are needed to determine functional (overground) walking economy, since 
this might affect functional activity, participation, and overall quality of life in this 
population.  
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Strengths and limitations of the review 
This is the first systematic review addressing the effects of aerobic exercise on 
cardiopulmonary function in PwP. The search included relevant studies from the last 40 
years and involved screening by two reviewers. However, it was not feasible to do meta-
analysis due to the heterogeneity of the data, and of the outcome measures, methods and 
protocols used in the included studies. Additional data that might have enabled effect size 
calculation was not made available by the authors.  
 
Summary and conclusion   
This review has collated the reported effects of aerobic training on cardiopulmonary 
function and walking economy in PwP and concludes that aerobic exercise could help in 
improving cardiac fitness and walking economy. However, no research has been done to 
investigate the effects of aerobic exercise specifically on pulmonary function using 
spirometry in PwP. Therefore, further research that may help to determine the effects of 
aerobic exercise on pulmonary function is warranted.  
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Figure 1: Flow-Chart of the search outcomes. PFT: pulmonary function test; CPET: 
cardiopulmonary exercise test. 
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Table 1: Summary of search strategy and records of findings
Search strategy
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Table 2: Quality assessment for the included studies.
PEDro scores for the studies that investigated the effects of aerobic training on cardiopulmonary function in people with Parkinson’s
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1 1 1 1 0 0 1 1 1 1 1 8
Burini et al, 
2006 1 1 1 1 0 0 1 1 1 1 1 8
Corbianco et al, 
2018 1 1 1 1 0 0 0 1 1 1 1 7
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G1: Cycling or treadmill 
walking for 3 times/week 
for 16 weeks. 
G2:  Usual activity
CPET Increased  V̇O2peak  and achieved workload in the 
intervention group (from 19.5 to 24.5 ml.kg.min-1 
). 
Decreased V̇O2peak  in the control group (from 








9:4 RCT G1: 12 weeks aerobic 
exercise (walking). 
G2: Usual physical activity 
level
CPET Improvement in exercise test duration and HR in 
the exercise group
 The exercise group had a mean (SE) minimum 
target heart rate of 82.92 (9.98) beats per 
minute and exercised at an intensity that 
produced a mean (SE) maximum HR of 
121.27 (16.74) beats per minute.
 Significant group by session interactions 
between the exercise and control groups in 
mean CPET duration (p=0.047).






9:17 RCT G1: Aerobic training 3 
times/week for 7 weeks.
G2: Qigong exercises 3 
times/week for 7 weeks.
CPET  G1: mean (SD) V̇O2peak (ml.kg.min-1 ) at 
baseline =1201.4 (368), and 951 (337) after 7 
weeks, within-group mean difference = 250 
(t=2.3, p=0.04)
 G2: mean (SD) V̇O2peak (ml.kg.min-1 ) at 
baseline =1064.7(229), and 1158(307) after 7 
weeks, (mean difference=-94); within-group 
mean difference = -94 (p=0.02)








20:0 RCT G1: treadmill training 20 
minutes per day, 4 
days/week for 4 weeks 
VO2 peak increased in both groups (ml.kg.min-1):
G1: baseline mean (SD) V̇O2peak (13.46(4.96)), 
after 4 weeks (18.55(1.11))










G2: Whole body vibration 
20 minutes per day, 4 
days/week for 4 weeks
G2:  baseline mean (SD) V̇O2peak (13.22(6.16)), 
after 4 weeks (20.70(1.16))







58.7(10) 13:9 RCT G1: Treadmill training 3 
times/week for 5 weeks. 
G2: Overground training 3 




Treadmill training but not overground training 
reduced overground walking economy (p <0.001 
for treadmill training).




et al, 2017 
36 G1;
47 G2
67(8) 61:22 RCT G2: Treadmill, cycle 
ergometer, cross-trainer or 
rowing ergometer 2 
times/week for 24 weeks. 
G2: Usual activity
CPET G2 obtained higher maximum values for HR, VO2 
peak.
 Mean (SD) V̇O2peak (ml.kg.min-1):
G1 =1.66 (2.35), G2= 1.69 (2.57) 
 Mean (SD) HR peak (beats.min-1):
(G1=136 (114), G2=152 (108))
Significant difference between the two groups for 
V̇O2peak (p=0.008).






19:5 RCT G1: Combined intensive 
therapy including cycle 
resistance and aerobic 
exercises 3 times/week for 
12 weeks.
G2: Usual activity.
CPET No significant differences between both groups 
for cardiovascular variables (resting HR (p=0.59), 
V̇O2 max (p=0.86)).  
Schenkman 






76:45 RCT G1: Supervised flexibility, 
balance and function, 3 
days/week for 3 months.
G2: Supervised aerobic 
exercise, 3 days/week for 
16 months.
G3: Control (home 
exercise), single supervised 
session and then 5–7 
days/week for 16 months 
Walking 
economy 
Walking economy was improved in the aerobic 
exercise group but not in the flexibility, balance 
and function group or the control group (mean 
difference= -1.2 ml.kg.min-1, 95% CI = -1.9 to -
0.5).


















50:17 RCT G1: Low-intensity treadmill 
training, 3 times/week for 
3 months.
G2: High-intensity treadmill 
training, 3 times/week for 
3 months.
G3: Stretching and 
resistance training, 3 
times/week for 3 months.
CPET Low-intensity treadmill intervention had the 
greatest effect in improving gait speed.
Both treadmill interventions decreased maximum 
V̇O2.
Mean difference(SD) between baseline and post 
training  (ml.kg.min-1): 
 Low intensity (1.54 (0.4))
 High intensity (1.53 (0.7))
Statistically significant with p=0.003
SD: standard deviation; G1: group 1; G2: group 2; G3: group 3; CPET: cardiopulmonary exercise test;  V̇O2: oxygen consumption; RCT: randomized 
controlled trial; HR: heart rate; SE: standard error.
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